Can-Fite Biopharma Ltd ADR
(CANF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,825 | 4,278 | 2,978 | 4,390 | 8,268 |
| Marketable Securities | 3,062 | 4,644 | 5,009 | 14,749 | 75 |
| Receivables | N/A | N/A | N/A | N/A | 1,057 |
| TOTAL | $8,982 | $9,908 | $9,157 | $20,068 | $9,400 |
| Non-Current Assets | |||||
| PPE Net | 27 | 29 | 42 | 47 | 50 |
| Other Non-Current Assets | 111 | 52 | 84 | 138 | 73 |
| TOTAL | $138 | $81 | $126 | $185 | $123 |
| Total Assets | $9,120 | $9,989 | $9,283 | $20,253 | $9,523 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,594 | 1,371 | 1,671 | 1,859 | 892 |
| TOTAL | $2,052 | $2,020 | $2,502 | $2,730 | $1,269 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 405 | 622 | 783 | 818 | 334 |
| Other Non-Current Liabilities | 51 | 13 | 14 | 71 | 24 |
| TOTAL | $1,632 | $1,726 | $2,309 | $3,141 | $2,180 |
| Total Liabilities | $3,684 | $3,746 | $4,811 | $5,871 | $3,449 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | N/A | N/A | 33,036 |
| Retained earnings | -166,361 | -158,481 | -150,847 | -140,674 | -125,469 |
| Other shareholders' equity | 1,127 | 1,127 | 1,127 | 1,127 | 1,127 |
| TOTAL | $5,436 | $6,243 | $4,472 | $14,382 | $6,074 |
| Total Liabilities And Equity | $9,120 | $9,989 | $9,283 | $20,253 | $9,523 |